4//SEC Filing
Cartwright Daniel A 4
Accession 0001387131-18-006726
CIK 0000025743other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 8:02 PM ET
Size
8.9 KB
Accession
0001387131-18-006726
Insider Transaction Report
Form 4
Cartwright Daniel A
CFO, VP Finance, Treasurer
Transactions
- Sale
Common Stock
2018-12-06$4.57/sh−40,000$182,800→ 40,000 total - Exercise/Conversion
Common Stock
2018-12-06$0.38/sh+40,000$15,200→ 40,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2018-12-06−40,000→ 180,000 totalExercise: $0.38From: 2012-10-21Exp: 2021-10-21→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.44 to $4.68, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001532231
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 8:02 PM ET
- Size
- 8.9 KB